These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11714407)

  • 1. Genetic counselling for hypertrophic cardiomyopathy: are we ready for it?
    Vosberg HP
    Curr Control Trials Cardiovasc Med; 2000; 1(1):41-44. PubMed ID: 11714407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophic cardiomyopathy repealing tenets in South Africa.
    Moolman-Smook JC; De Lange J; Brink A; Corfield A
    Cardiovasc J S Afr; 2000 Aug; 11(4):202-209. PubMed ID: 11447480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
    Marian AJ; Braunwald E
    Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences of cardiologists and clinical geneticists for the future organization of genetic care in hypertrophic cardiomyopathy: a survey.
    van Langen IM; Birnie E; Schuurman E; Tan HL; Hofman N; Bonsel GJ; Wilde AA
    Clin Genet; 2005 Oct; 68(4):360-8. PubMed ID: 16143023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death].
    Baars HF; Christiaans I; de Nijs PT; Cramer MJ; van Langen IM; Doevendans PA
    Ned Tijdschr Geneeskd; 2010; 154():A698. PubMed ID: 20132578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.
    Tardiff JC
    Heart Fail Rev; 2005 Sep; 10(3):237-48. PubMed ID: 16416046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
    Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
    Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic causes of hypertrophic cardiomyopathy].
    Vosberg HP
    Med Klin (Munich); 1998 Apr; 93(4):252-9. PubMed ID: 9594535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sudden death (V). Identification and treatment of patients with hypertrophic cardiomyopathy at risk of sudden death].
    McKenna WJ; Monserrat Iglesias L
    Rev Esp Cardiol; 2000 Jan; 53(1):123-30. PubMed ID: 10701329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening.
    Christiaans I; Birnie E; van Langen IM; van Spaendonck-Zwarts KY; van Tintelen JP; van den Berg MP; Atsma DE; Helderman-van den Enden AT; Pinto YM; Hermans-van Ast JF; Bonsel GJ; Wilde AA
    Eur Heart J; 2010 Apr; 31(7):842-8. PubMed ID: 20019025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathology of hypertrophic cardiomyopathy.
    Hughes SE
    Histopathology; 2004 May; 44(5):412-27. PubMed ID: 15139989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertrophic cardiomyopathy: genetics and clinical perspectives.
    Wolf CM
    Cardiovasc Diagn Ther; 2019 Oct; 9(Suppl 2):S388-S415. PubMed ID: 31737545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Stratification in Hypertrophic Cardiomyopathy.
    Steriotis AK; Sharma S
    Eur Cardiol; 2015 Jul; 10(1):31-36. PubMed ID: 30310420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
    Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
    Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation screening of the PTPN11 gene in hypertrophic cardiomyopathy.
    Limongelli G; Hawkes L; Calabro R; McKenna WJ; Syrris P
    Eur J Med Genet; 2006; 49(5):426-30. PubMed ID: 16488201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.